Rachel M.Long

Associate

Chicago + 1.312.269.1502

Connect

Share

Rachel Long practices in the area of employee benefits and executive compensation.

Rachel advises public and private companies on the compensation and benefits aspects of corporate acquisitions, dispositions, and mergers. She also advises clients regarding the design and administration of equity incentive and deferred compensation arrangements and the compliance of employee benefit plans, programs, and arrangements with the Internal Revenue Code and the Employee Retirement Income Security Act (ERISA). In addition, Rachel has experience drafting employment agreements, separation agreements, and documentation related to the golden parachute payment tax implications of executive compensation arrangements in private company transactions.

Erfahrung

  • Reneo Pharmaceuticals announces reverse merger with OnKureJones Day represented Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) in an all-stock reverse merger between Reneo and OnKure, Inc., a privately-held, clinical-stage biopharmaceutical company valued at $170 million that is focused on the development of novel precision medicines in oncology.
  • Five9 acquires AcqueonJones Day advised Five9, Inc. in its acquisition of Acqueon, a pioneering real-time revenue execution platform, realizing Five9's ambition to become the orchestration engine for every interaction across the entire customer journey, including marketing, e-commerce, sales and customer service through AI-driven, omnichannel proactive customer engagement.
  • Spark Networks obtains chapter 15 recognition of first-ever cross-border restructuring under German StaRUGJones Day represented Spark Networks SE in the first-ever cross-border restructuring under the recently enacted German restructuring law ("StaRUG") and chapter 15 of the U.S. Bankruptcy Code involving over $100 million of funded debt issued by a U.S.-based credit fund and guaranteed by other German and U.S. entities.
  • Riverside portfolio company acquires jobZologyJones Day represented The Riverside Company in connection with the acquisition by portfolio company PeopleGrove of jobZology and its flagship product PathwayU, a SaaS-based solution that assists higher education students with identifying career pathways by leveraging predictive assessments.
  • Sumitomo acquires assets and rights related to lefamulin from NabrivaJones Day advised Sumitomo Pharma Co., Ltd. in the acquisition of assets from Nabriva Therapeutics plc and various wholly-owned subsidiaries. This acquisition includes assets from the U.S., Ireland, and Austria in support of the development, manufacture, marketing and commercialization of lefamulin in the People’s Republic of China, Hong Kong, Macau and Taiwan.
  • Riverside portfolio company acquires LightHouse Business Information SolutionsJones Day represented The Riverside Company in connection with the acquisition by portfolio companies ProVelocity and IronEdge Group of LightHouse Business Information Solutions, which provides comprehensive outsourced IT services primarily to businesses across professional services, industrials, healthcare, and non-profit verticals in New Mexico and the Midwest.
  • Rockwood Equity Partners sells BJG Electronics, Inc. to FDH AeroJones Day advised Rockwood Equity Partners LLC in connection with its sale of portfolio company BJG Electronics, Inc. ("BJG"), a global supplier of interconnect and electromechanical products to the world’s leading OEMs in the defense, commercial aviation, business aviation, space, oil and gas, and industrial markets, to FDH Aero ("FDH"), a portfolio company of Audax Private Equity.
  • Riverside portfolio company acquires Student Opportunity CenterJones Day represented The Riverside Company in connection with the acquisition by portfolio company PeopleGrove of Student Opportunity Center (SOC), the leading service provider for Experiential Learning (EL), High-Impact Practices (HIPs), and EL/HIPs operational consulting services.
  • Investor Group of Apollo, J.F. Lehman & Company and Hill City Capital acquires Atlas Air Worldwide for $5.2 billionJones Day advised J.F. Lehman & Company and Hill City Capital in their participation in a consortium with Apollo for the acquisition of Atlas Air Worldwide (NASDAQ: AAWW) in an all cash transaction with an enterprise value of approximately $5.2 billion.
  • Stellex completes buyout of David Brown Santasalo GroupJones Day advised Stellex Capital Management LLC on its buyout of DB Santasalo S.à r.l from N4 Partners.
  • Riverside acquires ProVelocity and IronEdgeJones Day represented The Riverside Company in the acquisition of ProVelocity, a long-standing managed IT solutions provider that helps businesses and government agencies manage their technology needs, and IronEdge, a leading IT solutions provider for Texas-based businesses.
  • Organon makes strategic investment in Claria MedicalJones Day advised Organon in the strategic investment in Claria Medical, Inc. a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy.
  • Ansys acquires automotive simulation channel partner DYNAmoreJones Day is representing Ansys, Inc. in the acquisition of the DYNAmore business (“DYNAmore”), a Stuttgart, Germany-headquartered company who has historically distributed Ansys’ LS-DYNA crash test simulation software to virtually all major European car manufacturers.
  • Ahlström Capital makes strategic investment in Bast Fibre TechnologiesJones Day advised Ahlström Capital in its acquisition of 20% of Bast Fibre Technologies Inc., a manufacturer of 100% plant-based, intact natural fibres with the technical and performance requirements for a wide variety of nonwoven applications.
  • CDPQ leads $125 million Series D financing of Soli OrganicJones Day advised CDPQ as lead investor in the $125 million Series D financing of Soli Organic, the nation's only soil-based, indoor farming company delivering 100% USDA certified organic produce.
  • Riverside portfolio company acquires BloodHubJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company InVita Healthcare Technologies of BloodHub, a leading software provider of blood and biologics supply chain automation solutions.
  • Riverside portfolio company acquires ProCode, Inc. and 4R3 Software Solutions, Ltd.Jones Day represented The Riverside Company in connection with the acquisition by portfolio company SAFEbuilt, LLC of ProCode, Inc., a provider of engineering consulting services, plan review, and inspection services for municipalities and local governments, and 4R3 Software Solutions, Ltd., an online software and portal solution that enables clients to manage and track construction projects, obtain permits and licenses, pay fees, and review and approve construction plans.
  • Riverside acquires PaleoWestJones Day advised The Riverside Company in its acquisition of PaleoWest, a professional consultancy that assists clients with their need to address federal, state, and local level environmental regulations, typically in support of a wide variety of land development projects such as the permitting of solar and wind generation facilities, housing developments, roads and bridges, and other major infrastructure development projects.
  • Husqvarna acquires Orbit IrrigationJones Day advised Husqvarna AB on the acquisition of Lunar Holding Corporation ("Orbit Irrigation") for $480 million in cash.
  • Sempra Energy sells PXiSE Energy SolutionsJones Day advised Sempra Energy in the sale of membership interests in PXiSE Energy Solutions to Yokogawa Electric Corporation.
    •

    Bitte beachten Sie vor dem Versenden:

    Die Informationen auf unserer Website sind für den allgemeinen Gebrauch und stellen keine Rechtsberatung dar. Der Versand dieser E-Mail ist nicht dazu bestimmt, ein Mandatsverhältnis zu begründen, und der Erhalt dieser E-Mail stellt kein Mandatsverhältnis dar. Alles, was Sie an jemanden in unserer Kanzlei senden, ist nicht vertraulich oder privilegiert, es sei denn, wir haben zugestimmt, Sie zu vertreten. Wenn Sie diese E-Mail versenden, bestätigen Sie, dass Sie diesen Hinweis gelesen und verstanden haben.